Treatment of pembrolizumab-induced bullous pemphigoid with dupilumab: A case report and review of the literature

Int J Dermatol. 2024 Dec 30. doi: 10.1111/ijd.17626. Online ahead of print.

Authors

Armeen Barghi^{1

2}, Sasan D Noveir^{1

2}, Walker Mainwaring², Nima Milani-Nejad², Laura Bernet²

Affiliations

¹ David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA.
² Division of Dermatology, Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA.

PMID: 39739856
DOI: 10.1111/ijd.17626

No abstract available

Keywords: bullous pemphigoid; dupilumab; eosinophilic annular erythema; immune checkpoint inhibitor; pembrolizumab.

Publication types

Letter